The Global Epidemic of Atherosclerotic Cardiovascular Disease

Of the 50 million deaths that occur in the world, 40 million occur in developing countries. Already a substantial proportion of these deaths are due to cardiovascular diseases. It is projected that by the year 2025 well over 80–90% of all the cardiovascular diseases in the world will be occurring in low income and middle income countries. This increase in cardiovascular disease is due to a number of causes which include the following: (1) conquest of deaths in childhood and infancy from nutritional deficiencies and infection; (2) urbanization with increasing levels of obesity; (3) increasing longevity of the population so that a higher proportion of individuals reach the age when they are subject to chronic diseases, and (4) increasing use of tobacco worldwide. In most countries in the world other than those in the West, the burden of disease is still due to a combination of infections and nutritional disorders as well as those due to chronic diseases. This double burden of disease poses a challenge that is not only medical and epidemiological, but also social and political. Tackling this projected global epidemic of cardiovascular disease therefore needs policies that combine sound knowledge of prevention, good clinical care, but also deals with the allocation of resources for both individual level and community level preventive strategies. The former involves dealing with high-risk individuals through appropriate medical and therapeutic interventions. The latter involves societal level changes including laws that curb the use of tobacco, and strategies that promote physical activities, and appropriate nutrition.

[1]  P. Connelly,et al.  Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration , 1997 .

[2]  B. Popkin,et al.  Body weight patterns among the Chinese: results from the 1989 and 1991 China Health and Nutrition Surveys. , 1995, American Journal of Public Health.

[3]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[4]  H Schultz,et al.  Tobacco or health: A global status report. , 1998, Annals of Saudi medicine.

[5]  A. Omran The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.

[6]  C. Hales,et al.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.

[7]  L. Wilkins An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. People's Republic of China--United States Cardiovascular and Cardiopulmonary Epidemiology Research Gr , 1992 .

[8]  V. Kaul,et al.  Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan. , 1997, The Journal of the Association of Physicians of India.

[9]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[10]  B. Zinman,et al.  Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Drewnowski,et al.  The nutrition transition: new trends in the global diet. , 2009, Nutrition reviews.

[12]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[13]  Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[14]  C. Murray,et al.  Global burden of disease , 1997, The Lancet.

[15]  R. Peto TOBACCO-RELATED DEATHS IN CHINA , 1987, The Lancet.

[16]  N. Wenger,et al.  Relation of three genetic traits to venous thrombosis in an African-American population. , 1998, American journal of epidemiology.

[17]  V. Gupta,et al.  Meta-analysis of coronary heart disease prevalence in India. , 1996, Indian heart journal.

[18]  C. Yajnik,et al.  -to: Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595–601 , 2003, Diabetologia.

[19]  J. Everhart,et al.  High temporal, geographic, and income variation in body mass index among adults in Brazil. , 1994, American journal of public health.